Literature DB >> 20924774

Tissue-type plasminogen activator gene targets thrombolysis in atriums.

Yongsheng Gong1, Fajiu Wang, Xia Li, Zhixin Gao, Kailun Zhang, Chen Fan, Xingen Liu.   

Abstract

Our previous investigations showed that retroviral gene transfer of tissue-type plasminogen activator (tPA) effectively targeted thrombolysis in vitro and in the model of inferior caval veins of rabbits. This study is to identify the target thrombolysis of retroviral vector recombinant pLEGFP-N1-tPA transferred into the tissue around the Dacron patch (the same materials making of the ring of mechanical valve) in left atriums of rabbits. 70 Dacron patches were transplanted into the left atriums of 70 New Zealand white rabbits. The rabbits were randomly divided into three groups according to the different handling methods, including local pLEGFP-N1-tPA transferred group (gene therapy group, 30 animals), pLEGFP-N1 transferred group (control group, 20 animals), medium DMEM + 10% neonate calf serum (NCS) injected group (blank control group, 20 animals). Samples of blood, Dacron pieces and left atriums (auricles) wall from half of above in each group were harvested on second day and another half were harvested on 75th day after surgery. The EGFP expression of harvested left atriums (auricles) wall were observed under the confocal. The thrombi on the surface of Dacron patches were detected by stereoscope and electron microscope. The tPA expression in left atriums (auricles) wall and in blood from left atriums were detected by Western blot and their thrombolysis and activities were observed and calculated in plasma plates. ELISA were used to identify the contents of tPA. No thrombus was seen on the surface of Dacron patches that were transplanted in left atriums by tPA locally transferring around them. Activity and content of tPA were high in local tissue of left atrium and in blood of left atrium. It demonstrated effectively thrombolysis by tPA rapidly, efficiently and long expressing. This puts the foundation of mechanical valve replacement model for tPA gene valve, next.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20924774     DOI: 10.1007/s11239-010-0523-z

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  40 in total

1.  Enhanced green fluorescent protein as selectable marker of retroviral-mediated gene transfer in immature hematopoietic bone marrow cells.

Authors:  M F Bierhuizen; Y Westerman; T P Visser; W Dimjati; A W Wognum; G Wagemaker
Journal:  Blood       Date:  1997-11-01       Impact factor: 22.113

Review 2.  Current and future recanalization strategies for acute ischemic stroke.

Authors:  A V Alexandrov
Journal:  J Intern Med       Date:  2010-02       Impact factor: 8.989

3.  Packaging cell line characteristics and optimizing retroviral vector titer: the National Gene Vector Laboratory experience.

Authors:  L Reeves; P Smucker; K Cornetta
Journal:  Hum Gene Ther       Date:  2000-10-10       Impact factor: 5.695

4.  Involvement of calcium and G proteins in the acute release of tissue-type plasminogen activator and von Willebrand factor from cultured human endothelial cells.

Authors:  Y van den Eijnden-Schrauwen; D E Atsma; F Lupu; R E de Vries; T Kooistra; J J Emeis
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-10       Impact factor: 8.311

5.  Retroviral gene transfer of tissue-type plasminogen activator targets thrombolysis in vitro and in vivo.

Authors:  Y S Gong; K L Zhang; X G Jiang; Z W Wang; Z Q Sun; J Cai
Journal:  Gene Ther       Date:  2007-08-30       Impact factor: 5.250

6.  Aortic valve replacement: a prospective randomized evaluation of mechanical versus biological valves in patients ages 55 to 70 years.

Authors:  Paolo Stassano; Luigi Di Tommaso; Mario Monaco; Francesco Iorio; Paolo Pepino; Nicola Spampinato; Carlo Vosa
Journal:  J Am Coll Cardiol       Date:  2009-11-10       Impact factor: 24.094

Review 7.  Retroviruses.

Authors:  H Varmus
Journal:  Science       Date:  1988-06-10       Impact factor: 47.728

Review 8.  Valve replacement options in the setting of an ascending aortic aneurysm.

Authors:  Stephen H McKellar; Thoralf M Sundt
Journal:  Future Cardiol       Date:  2009-07

9.  Incidence and risk factors of early thromboembolic events after mechanical heart valve replacement in patients treated with intravenous unfractionated heparin.

Authors:  N Allou; P Piednoir; C Berroëta; S Provenchère; H Ibrahim; G Baron; P Montravers; B Iung; I Philip; N Ajzenberg
Journal:  Heart       Date:  2009-05-28       Impact factor: 5.994

10.  Retroviral vectors encoding ADA regulatory locus control region provide enhanced T-cell-specific transgene expression.

Authors:  Alice T Trinh; Bret G Ball; Erin Weber; Timothy K Gallaher; Zoya Gluzman-Poltorak; French Anderson; Lena A Basile
Journal:  Genet Vaccines Ther       Date:  2009-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.